Across TCGA pan-cancer cohorts, OR5M5P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated OR5M5P data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR5M5P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR5M5P expression acts as an unfavorable survival marker, although some lineages such as COAD and ESCA show a favorable association.
STAD, KIRC, and PRAD are the cancer types where OR5M5P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.